New Age Beverages (NASDAQ:NBEV)‘s stock had its “buy” rating restated by investment analysts at Aegis in a research report issued on Monday, December 4th.
Several other research firms have also recently weighed in on NBEV. TheStreet cut New Age Beverages from a “c” rating to a “d+” rating in a research note on Monday, August 7th. Zacks Investment Research lowered New Age Beverages from a “buy” rating to a “hold” rating in a report on Friday, September 8th. Finally, Maxim Group cut their price objective on New Age Beverages from $7.50 to $6.00 and set a “buy” rating for the company in a report on Friday, November 17th. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $5.63.
New Age Beverages (NBEV) traded up $0.09 during mid-day trading on Monday, hitting $2.17. The stock had a trading volume of 236,197 shares, compared to its average volume of 226,955. New Age Beverages has a 52-week low of $1.80 and a 52-week high of $7.20. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.21 and a quick ratio of 1.26.
About New Age Beverages
The New Age Beverage Corporation, formerly Bucha, Inc, is a healthy functional beverage company. The Company is the owner of XingTea, XingEnergy, Aspen Pure and the Bucha Live Kombucha brands. The Company’s bucha Live Kombucha is a gluten free, organic certified, sparkling kombucha tea and is distributed in health and grocery chains across North America.
Receive News & Ratings for New Age Beverages Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New Age Beverages and related companies with MarketBeat.com's FREE daily email newsletter.